Taiwan's Food and Drug Administration (FDA) on Thursday made public its standards in granting emergency use authorizations (EUA) for locally developed COVID-19 vaccines, with one requirement being that the domestic vaccine candidates have to offer at least the same level of protection as that of the AstraZeneca (AZ) vaccine.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Downpours forecast for northern, eastern Taiwan early next week
10/15/2025 11:41 AM - Business
U.S. dollar down in Taipei trading
10/15/2025 10:45 AM - Society
Taiwan headline news
10/15/2025 10:34 AM - Business
Taiwan shares open higher
10/15/2025 09:15 AM - Politics
TPP leader denies recruiting hackers after RTI website breach
10/14/2025 10:03 PM